Home » Newsletters » BioWorld Asia

BioWorld Asia

June 9, 1999

View Archived Issues

SmithKline Passes On Vaccine Being Developed By Amrad

Polymorphism In TNF Promoter Increases Likelihood Of Malaria

Commission Suggests More Controls On Biotech Products

Cerebrus Licenses Alzheimers Drug Thats Reached Phase III

CAT Issues Aptein More Shares

Surveys Show Biotech Out Of Favor With Most Europeans

Relenzas European Approval Helps Renew Interest In Biota

MediGene Validates Target Involved In Heart Failure

TAB Seeks Partner To Move Sepsis Product Into Phase III

Theratechnologies To Create Subsidiary Based On Peptides

LION Adds To Platform, Completes Licensing Deal

Oxford Biomedica Shows Genes Carried to HIV Cells

Shield, Axis Complete Merger, To Focus On In Vitro Products

Pharming Group Prepares To Start Phase III Study

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...